60 Degrees Pharmaceuticals, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−29.2919 USD
−7.95 M USD
681.35 K USD
1.02 M
About 60 Degrees Pharmaceuticals, Inc.
Sector
Industry
CEO
Geoffrey S. Dow
Website
Headquarters
Washington
Founded
2010
Identifiers
3
ISIN US83006G1123
60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.
Displays a symbol's price movements over previous years to identify recurring trends.